Soterius' Game-Changing Biosensor Set to Revolutionize COVID-19 Detection
Innovative Australian start-up Soterius is set to revolutionise COVID-19 detection with its groundbreaking Soterius Scout biosensor. The device, developed in collaboration with RMIT University, promises rapid, accurate, and non-invasive detection of the SARS-CoV-2 virus and its variants.
The Soterius Scout biosensor has shown remarkable results in prototype testing. It can detect SARS-CoV-2 spike protein fragments with impressive accuracy and zero false positives. Furthermore, it can identify up to 8 viral strains and be adapted to detect new variants or even novel viruses. The sensor provides results within a minute, making it a reliable and efficient diagnostic tool for covid symptoms.
Expressions of interest are now open for investors eager to support this promising technology. Initial deliveries will prioritise hospitals, with future applications expanding to aged care facilities, quarantine hotels, airports, and schools. Soterius is committed to manufacturing the sensor in Australia, with commercial release slated for early 2022.
The Soterius Scout's potential extends beyond covid. Trials suggest it could become a top performer in detecting other respiratory illnesses, including influenza and MERS. Moreover, it can detect the virus even in asymptomatic individuals, helping to curb the spread of infection.
The Soterius Scout biosensor, a product of Soterius and RMIT University's collaboration, is poised to transform covid detection. With its speed, accuracy, and non-invasive nature, it promises to enhance safety and peace of mind in various settings. As the sensor progresses towards commercial release, expressions of interest from investors are welcome.
Read also:
- Mobility Sparks Unseen Organ: Surprisingly Active During Physical Activity
- Early Onset Puberty: Its Definition, Triggers, Risks, and Managing Strategies
- "Satanic Worship Owns the Spotlight in America: QAnon Spurring Modern Day Satanic Panic"
- Vaccine Deployment Amidst Adversity: HPV Inoculations Commence in Flood-Hit Regions Spite of Widespread Resistance from Society
